mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | |||||||
|---|---|---|---|---|---|---|---|
| evidence | seq id | position | mutation | freq | annotation | gene | description |
| RA | NZ_CP022686 | 47,354 | G→T | 11.0% | P665P (CCG→CCT) | vgrG → | type VI secretion system tip protein TssI/VgrG |
| RA | NZ_CP022686 | 119,184 | T→G | 10.5% | F47V (TTT→GTT) | marB → | multiple antibiotic resistance protein MarB |
| RA | NZ_CP022686 | 238,317 | G→T | 20.2% | L88I (CTT→ATT) | sufE ← | cysteine desulfuration protein SufE |
| RA | NZ_CP022686 | 238,324 | G→C | 17.7% | V85V (GTC→GTG) | sufE ← | cysteine desulfuration protein SufE |
| RA | NZ_CP022686 | 263,831 | A→C | 11.5% | intergenic (+38/+19) | fadK → / ← ppsA | medium‑chain fatty‑acid‑‑CoA ligase/phosphoenolpyruvate synthase |
| RA | NZ_CP022686 | 298,027 | A→C | 9.3% | F60C (TTT→TGT) | chbC ← | PTS N,N'‑diacetylchitobiose transporter subunit IIC |
| RA | NZ_CP022686 | 349,092 | A→C | 10.4% | N602T (AAC→ACC) | yeaG → | protein kinase YeaG |
| RA | NZ_CP022686 | 349,106 | A→C | 13.2% | T607P (ACC→CCC) | yeaG → | protein kinase YeaG |
| RA | NZ_CP022686 | 349,123 | A→C | 10.6% | K612N (AAA→AAC) | yeaG → | protein kinase YeaG |
| RA | NZ_CP022686 | 360,246 | T→G | 13.4% | E28D (GAA→GAC) | yeaR ← | DUF1971 domain‑containing protein YeaR |
| RA | NZ_CP022686 | 372,574 | A→C | 16.8% | N275T (AAC→ACC) | sdaA → | L‑serine ammonia‑lyase |
| RA | NZ_CP022686 | 457,894 | Δ1 bp | 100% | pseudogene (288/997 nt) | CIW80_RS02445 ← | DUF968 domain‑containing protein |
| RA | NZ_CP022686 | 496,135 | A→C | 10.3% | V382V (GTT→GTG) | otsA ← | alpha,alpha‑trehalose‑phosphate synthase |
| RA | NZ_CP022686 | 560,880 | C→T | 100% | intergenic (+62/+53) | CIW80_RS03085 → / ← pilV | hypothetical protein/shufflon system plasmid conjugative transfer pilus tip adhesin PilV |
| RA | NZ_CP022686 | 596,637 | T→G | 8.8% | G54G (GGT→GGG) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
| RA | NZ_CP022686 | 601,295 | T→G | 16.8% | V1607G (GTC→GGC) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
| RA | NZ_CP022686 | 601,302 | T→G | 21.4% | R1609R (CGT→CGG) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
| MC JC | NZ_CP022686 | 628,478 | Δ1,286 bp | 100% | [clbP] | [clbP] | |
| RA | NZ_CP022686 | 636,713 | A→C | 8.0% | R452R (CGT→CGG) | clbM ← | precolibactin export MATE transporter ClbM |
| RA | NZ_CP022686 | 636,764 | G→C | 7.4% | V435V (GTC→GTG) | clbM ← | precolibactin export MATE transporter ClbM |
| RA | NZ_CP022686 | 694,391 | C→A | 13.8% | intergenic (+151/‑45) | CIW80_RS03555 → / → CIW80_RS03560 | transposase/PfkB family carbohydrate kinase |
| RA | NZ_CP022686 | 756,115 | A→G | 100% | G181G (GGT→GGC) | galE ← | UDP‑glucose 4‑epimerase GalE |
| RA | NZ_CP022686 | 764,997 | T→G | 15.6% | N41T (AAC→ACC) | wcaM ← | colanic acid biosynthesis protein WcaM |
| RA | NZ_CP022686 | 794,460 | C→T | 100% | A568V (GCG→GTG) | dgcE → | diguanylate cyclase |
| RA | NZ_CP022686 | 829,441 | C→A | 19.8% | intergenic (‑30/+197) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
| RA | NZ_CP022686 | 829,452 | G→T | 22.6% | intergenic (‑41/+186) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
| RA | NZ_CP022686 | 881,733 | A→C | 14.4% | intergenic (+248/+139) | yohP → / ← dusC | protein YohP/tRNA dihydrouridine(16) synthase DusC |
| RA | NZ_CP022686 | 881,742 | A→C | 21.0% | intergenic (+257/+130) | yohP → / ← dusC | protein YohP/tRNA dihydrouridine(16) synthase DusC |
| RA | NZ_CP022686 | 881,760 | T→G | 22.6% | intergenic (+275/+112) | yohP → / ← dusC | protein YohP/tRNA dihydrouridine(16) synthase DusC |
| RA | NZ_CP022686 | 917,427:1 | +TT | 100% | intergenic (+130/‑91) | yeiP → / → yeiQ | elongation factor P‑like protein YeiP/mannitol dehydrogenase family protein |
| RA | NZ_CP022686 | 948,046 | G→T | 12.9% | intergenic (+115/‑142) | CIW80_RS04855 → / → CIW80_RS04860 | terminase small subunit/hypothetical protein |
| RA | NZ_CP022686 | 957,112 | T→G | 13.0% | T89P (ACC→CCC) | ccmA ← | cytochrome c biogenesis heme‑transporting ATPase CcmA |
| RA | NZ_CP022686 | 973,436 | A→C | 5.1% | D253A (GAC→GCC) | rcsD → | phosphotransferase RcsD |
| RA | NZ_CP022686 | 1,005,073 | A→C | 11.9% | E376D (GAA→GAC) | nrdA → | ribonucleoside‑diphosphate reductase subunit alpha |
| RA | NZ_CP022686 | 1,005,085 | C→A | 14.0% | T380T (ACC→ACA) | nrdA → | ribonucleoside‑diphosphate reductase subunit alpha |
| RA | NZ_CP022686 | 1,005,098 | G→C | 6.5% | D385H (GAC→CAC) | nrdA → | ribonucleoside‑diphosphate reductase subunit alpha |
| RA | NZ_CP022686 | 1,011,396 | G→T | 9.9% | intergenic (‑245/‑28) | glpT ← / → glpA | glycerol‑3‑phosphate transporter/anaerobic glycerol‑3‑phosphate dehydrogenase subunit A |
| RA | NZ_CP022686 | 1,011,419 | T→A | 8.7% | intergenic (‑268/‑5) | glpT ← / → glpA | glycerol‑3‑phosphate transporter/anaerobic glycerol‑3‑phosphate dehydrogenase subunit A |
| RA | NZ_CP022686 | 1,034,493 | T→G | 8.7% | T26P (ACC→CCC) | menC ← | o‑succinylbenzoate synthase |
| RA | NZ_CP022686 | 1,065,982 | G→T | 8.5% | V35V (GTC→GTA) | yfbS ← | SLC13 family permease |
| RA | NZ_CP022686 | 1,100,944 | T→G | 11.7% | D187A (GAC→GCC) | aroC ← | chorismate synthase |
| RA | NZ_CP022686 | 1,174,272 | A→C | 15.5% | intergenic (+1/‑43) | CIW80_RS05855 → / → CIW80_RS05860 | tRNA‑Val/tRNA‑Val |
| RA | NZ_CP022686 | 1,203,718 | T→G | 6.8% | R239R (CGT→CGG) | hemF → | oxygen‑dependent coproporphyrinogen oxidase |
| RA | NZ_CP022686 | 1,209,908 | T→G | 19.4% | D396A (GAC→GCC) | eutH ← | ethanolamine utilization protein EutH |
| RA | NZ_CP022686 | 1,213,479 | T→G | 10.4% | G420G (GGA→GGC) | eutE ← | aldehyde dehydrogenase EutE |
| RA | NZ_CP022686 | 1,269,551 | T→G | 6.6% | K1124N (AAA→AAC) | CIW80_RS06320 ← | DUF823 domain‑containing adhesin |
| RA | NZ_CP022686 | 1,280,117 | T→G | 7.1% | N8H (AAC→CAC) | yfgM ← | ancillary SecYEG translocon subunit YfgM |
| RA | NZ_CP022686 | 1,290,935 | A→C | 13.2% | S734R (AGT→AGG) | yfhM ← | alpha2‑macroglobulin |
| RA | NZ_CP022686 | 1,360,724 | G→T | 8.3% | intergenic (‑59/+265) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
| RA | NZ_CP022686 | 1,360,750 | G→T | 13.4% | intergenic (‑85/+239) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
| RA | NZ_CP022686 | 1,371,081 | C→A | 15.4% | P32Q (CCA→CAA) | bamD → | outer membrane protein assembly factor BamD |
| RA | NZ_CP022686 | 1,424,362 | A→T | 8.1% | intergenic (‑58/+5) | CIW80_RS07085 ← / ← CIW80_RS07090 | tRNA‑Arg/tRNA‑Arg |
| RA | NZ_CP022686 | 1,479,595 | G→C | 9.1% | intergenic (‑4/+189) | ftsB ← / ← ygbE | cell division protein FtsB/DUF3561 family protein |
| RA | NZ_CP022686 | 1,479,634 | G→C | 10.9% | intergenic (‑43/+150) | ftsB ← / ← ygbE | cell division protein FtsB/DUF3561 family protein |
| RA | NZ_CP022686 | 1,504,310 | G→T | 12.4% | M249I (ATG→ATT) | CIW80_RS07520 → | YgcG family protein |
| RA | NZ_CP022686 | 1,504,328 | G→T | 13.9% | M255I (ATG→ATT) | CIW80_RS07520 → | YgcG family protein |
| RA | NZ_CP022686 | 1,504,353 | G→C | 7.1% | A264P (GCT→CCT) ‡ | CIW80_RS07520 → | YgcG family protein |
| RA | NZ_CP022686 | 1,504,354 | C→A | 12.2% | A264D (GCT→GAT) ‡ | CIW80_RS07520 → | YgcG family protein |
| RA | NZ_CP022686 | 1,504,373 | G→C | 8.9% | K270N (AAG→AAC) | CIW80_RS07520 → | YgcG family protein |
| RA | NZ_CP022686 | 1,558,395 | A→C | 9.4% | K464N (AAA→AAC) | vgrG → | type VI secretion system Vgr family protein |
| RA | NZ_CP022686 | 1,564,573 | T→G | 11.7% | W192G (TGG→GGG) | CIW80_RS07780 → | ImcF‑related family protein |
| RA | NZ_CP022686 | 1,604,869 | G→C | 7.3% | G376G (GGC→GGG) | lplT ← | lysophospholipid transporter LplT |
| RA | NZ_CP022686 | 1,619,264 | C→A | 6.1% | intergenic (+53/+264) | yqeG → / ← CIW80_RS07990 | amino acid permease/tRNA‑Gly |
| RA | NZ_CP022686 | 1,632,508 | C→A | 10.5% | I168I (ATC→ATA) | arcC → | carbamate kinase |
| RA | NZ_CP022686 | 1,633,846 | T→G | 30.8% | N253T (AAC→ACC) | yqeB ← | selenium‑dependent molybdenum cofactor biosynthesis protein YqeB |
| RA | NZ_CP022686 | 1,674,244 | T→G | 15.1% | T182P (ACC→CCC) | ygfB ← | UPF0149 family protein YgfB |
| RA | NZ_CP022686 | 1,674,248 | T→G | 10.1% | Q180H (CAA→CAC) | ygfB ← | UPF0149 family protein YgfB |
| RA | NZ_CP022686 | 1,674,251 | C→G | 8.1% | P179P (CCG→CCC) | ygfB ← | UPF0149 family protein YgfB |
| RA | NZ_CP022686 | 1,674,260 | A→T | 9.2% | F176L (TTT→TTA) | ygfB ← | UPF0149 family protein YgfB |
| RA | NZ_CP022686 | 1,706,011 | G→T | 10.4% | intergenic (‑621/‑34) | yqgB ← / → metK | acid stress response protein YqgB/methionine adenosyltransferase |
| RA | NZ_CP022686 | 1,833,779 | T→G | 15.8% | K456N (AAA→AAC) | gspD ← | type II secretion system secretin GspD |
| RA | NZ_CP022686 | 1,833,799 | T→G | 11.7% | T450P (ACG→CCG) | gspD ← | type II secretion system secretin GspD |
| RA | NZ_CP022686 | 1,911,602 | T→G | 12.9% | N224T (AAC→ACC) | CIW80_RS09520 ← | MurR/RpiR family transcriptional regulator |
| RA | NZ_CP022686 | 1,925,317 | T→G | 6.3% | L146R (CTG→CGG) | ygiB → | DUF1190 family protein |
| RA | NZ_CP022686 | 1,925,332 | A→C | 9.6% | N151T (AAC→ACC) | ygiB → | DUF1190 family protein |
| RA | NZ_CP022686 | 1,954,923 | T→G | 18.0% | T92P (ACG→CCG) | ttdR ← | DNA‑binding transcriptional activator TtdR |
| RA | NZ_CP022686 | 2,049,089 | T→G | 21.0% | N256T (AAC→ACC) | deaD ← | ATP‑dependent RNA helicase DeaD |
| RA | NZ_CP022686 | 2,049,094 | G→T | 11.8% | T254T (ACC→ACA) | deaD ← | ATP‑dependent RNA helicase DeaD |
| RA | NZ_CP022686 | 2,049,112 | C→A | 11.0% | A248A (GCG→GCT) | deaD ← | ATP‑dependent RNA helicase DeaD |
| RA | NZ_CP022686 | 2,056,168 | A→C | 9.4% | G614G (GGT→GGG) | infB ← | translation initiation factor IF‑2 |
| RA | NZ_CP022686 | 2,056,193 | A→C | 5.9% | V606G (GTT→GGT) | infB ← | translation initiation factor IF‑2 |
| RA | NZ_CP022686 | 2,076,554 | T→G | 7.2% | intergenic (+24/‑209) | ispB → / → sfsB | octaprenyl diphosphate synthase/DNA‑binding transcriptional regulator SfsB |
| RA | NZ_CP022686 | 2,110,457 | T→G | 14.8% | K12N (AAA→AAC) | rplM ← | 50S ribosomal protein L13 |
| RA | NZ_CP022686 | 2,110,465 | T→G | 10.0% | T10P (ACC→CCC) | rplM ← | 50S ribosomal protein L13 |
| RA | NZ_CP022686 | 2,127,686 | C→G | 6.0% | E45Q (GAA→CAA) | yhdP ← | AsmA2 domain‑containing protein YhdP |
| RA | NZ_CP022686 | 2,130,829 | A→C | 10.3% | V237G (GTT→GGT) | mreC ← | rod shape‑determining protein MreC |
| RA | NZ_CP022686 | 2,148,109 | T→G | 11.0% | V124G (GTG→GGG) | panF → | sodium/pantothenate symporter |
| RA | NZ_CP022686 | 2,148,115 | T→G | 16.6% | L126R (CTG→CGG) | panF → | sodium/pantothenate symporter |
| RA | NZ_CP022686 | 2,148,136 | T→G | 12.1% | V133G (GTT→GGT) | panF → | sodium/pantothenate symporter |
| RA | NZ_CP022686 | 2,148,141 | T→G | 12.3% | F135V (TTC→GTC) | panF → | sodium/pantothenate symporter |
| RA | NZ_CP022686 | 2,150,071 | T→G | 8.0% | G290G (GGT→GGG) | prmA → | 50S ribosomal protein L11 methyltransferase |
| RA | NZ_CP022686 | 2,172,177 | A→C | 6.0% | G87G (GGT→GGG) | smg ← | DUF494 family protein Smg |
| RA | NZ_CP022686 | 2,185,075 | A→C | 8.6% | V46G (GTT→GGT) | rpsE ← | 30S ribosomal protein S5 |
| RA | NZ_CP022686 | 2,214,419 | T→C | 100% | K43R (AAA→AGA) | rpsL ← | 30S ribosomal protein S12 |
| RA | NZ_CP022686 | 2,215,198 | G→C | 5.6% | G43G (GGC→GGG) | tusC ← | sulfurtransferase complex subunit TusC |
| RA | NZ_CP022686 | 2,320,775 | C→T | 100% | G274S (GGC→AGC) | CIW80_RS11675 ← | DNA‑processing protein DprA |
| RA | NZ_CP022686 | 2,357,324 | A→C | 21.3% | N37T (AAC→ACC) | dcrB → | phage sensitivity protein DcrB |
| RA | NZ_CP022686 | 2,361,489 | T→G | 11.1% | V188G (GTT→GGT) | nikA → | nickel ABC transporter substrate‑binding protein |
| RA | NZ_CP022686 | 2,380,936 | A→C | 10.0% | K186N (AAA→AAC) | pitA → | inorganic phosphate transporter PitA |
| RA | NZ_CP022686 | 2,394,287 | T→G | 19.8% | N115T (AAC→ACC) | chuS ← | hematinate‑forming heme oxygenase ChuS |
| RA | NZ_CP022686 | 2,398,885 | A→C | 8.9% | S203R (AGC→CGC) | hutW → | heme anaerobic degradation radical SAM methyltransferase ChuW/HutW |
| RA | NZ_CP022686 | 2,408,861 | Δ1 bp | 100% | pseudogene (1097/3115 nt) | mdtF → | multidrug efflux pump RND permease MdtF |
| RA | NZ_CP022686 | 2,460,581 | A→C | 23.3% | intergenic (‑3/‑155) | yhjY ← / → tag | autotransporter outer membrane beta‑barrel domain‑containing protein/DNA‑3‑methyladenine glycosylase I |
| RA | NZ_CP022686 | 2,516,216 | T→C | 8.5% | S542S (TCT→TCC) | upaG → | trimeric autotransporter adhesin UpaG |
| RA | NZ_CP022686 | 2,516,577 | A→G | 9.7% | T663A (ACA→GCA) | upaG → | trimeric autotransporter adhesin UpaG |
| RA | NZ_CP022686 | 2,572,705 | A→C | 7.1% | G191G (GGT→GGG) | CIW80_RS12885 ← | ROK family protein |
| RA | NZ_CP022686 | 2,572,721 | A→C | 9.6% | F186C (TTT→TGT) | CIW80_RS12885 ← | ROK family protein |
| JC | NZ_CP022686 | 2,590,563 | +TTGG | 100% | coding (109/153 nt) | CIW80_RS26455 → | hypothetical protein |
| RA | NZ_CP022686 | 2,703,299 | A→C | 9.8% | intergenic (‑203/‑277) | yieP ← / → CIW80_RS13540 | FadR/GntR family transcriptional regulator/16S ribosomal RNA |
| RA | NZ_CP022686 | 2,718,627 | T→G | 6.8% | F510V (TTC→GTC) | ilvA → | threonine ammonia‑lyase, biosynthetic |
| RA | NZ_CP022686 | 2,719,166 | A→T | 6.3% | I122I (ATT→ATA) | ilvY ← | HTH‑type transcriptional activator IlvY |
| RA | NZ_CP022686 | 2,736,578 | C→A | 8.4% | T180T (ACC→ACA) | rffA → | dTDP‑4‑amino‑4,6‑dideoxygalactose transaminase |
| RA | NZ_CP022686 | 2,736,586 | A→C | 18.5% | Y183S (TAC→TCC) | rffA → | dTDP‑4‑amino‑4,6‑dideoxygalactose transaminase |
| RA | NZ_CP022686 | 2,743,563 | T→G | 11.7% | noncoding (65/87 nt) | CIW80_RS13750 → | tRNA‑Leu |
| RA | NZ_CP022686 | 2,743,613 | C→A | 15.8% | intergenic (+28/‑15) | CIW80_RS13750 → / → CIW80_RS13755 | tRNA‑Leu/tRNA‑Pro |
| RA | NZ_CP022686 | 2,801,864 | T→G | 7.2% | L16F (TTA→TTC) | CIW80_RS14030 ← | 2‑dehydro‑3‑deoxy‑6‑phosphogalactonate aldolase |
| RA | NZ_CP022686 | 2,808,127 | T→G | 12.9% | V441G (GTC→GGC) | ubiB → | ubiquinone biosynthesis regulatory protein kinase UbiB |
| RA | NZ_CP022686 | 2,808,145 | T→G | 5.8% | V447G (GTG→GGG) | ubiB → | ubiquinone biosynthesis regulatory protein kinase UbiB |
| RA | NZ_CP022686 | 2,834,886 | A→C | 10.2% | K597N (AAA→AAC) | polA → | DNA polymerase I |
| RA | NZ_CP022686 | 2,868,740 | T→G | 19.1% | Q22P (CAG→CCG) | fdoH ← | formate dehydrogenase O subunit beta |
| RA | NZ_CP022686 | 2,868,753 | T→G | 9.2% | T18P (ACC→CCC) | fdoH ← | formate dehydrogenase O subunit beta |
| RA | NZ_CP022686 | 2,871,422 | T→G | 7.9% | N149T (AAC→ACC) | fdnG ← | formate dehydrogenase‑N subunit alpha |
| RA | NZ_CP022686 | 2,904,856 | T→G | 10.4% | K237N (AAA→AAC) | ftsN ← | cell division protein FtsN |
| RA | NZ_CP022686 | 2,919,074 | T→G | 7.1% | D340A (GAC→GCC) | CIW80_RS14605 ← | hypothetical protein |
| RA | NZ_CP022686 | 2,920,428 | A→C | 9.5% | K68N (AAA→AAC) | CIW80_RS14610 → | bifunctional UDP‑sugar hydrolase/5'‑nucleotidase |
| RA | NZ_CP022686 | 2,994,693 | T→G | 8.7% | W162G (TGG→GGG) | yjaH → | DUF1481 domain‑containing protein |
| RA | NZ_CP022686 | 3,017,622 | A→C | 19.6% | K839N (AAA→AAC) | metH → | methionine synthase |
| RA | NZ_CP022686 | 3,070,986 | T→G | 12.6% | G53G (GGT→GGG) | CIW80_RS15290 → | 2‑oxoglutarate dehydrogenase E1 component |
| RA | NZ_CP022686 | 3,080,461 | T→G | 8.1% | R158R (CGT→CGG) | CIW80_RS15320 → | Ldh family oxidoreductase |
| RA | NZ_CP022686 | 3,086,834 | A→C | 8.4% | F708V (TTT→GTT) | uvrA ← | excinuclease ABC subunit UvrA |
| RA | NZ_CP022686 | 3,136,940 | T→G | 8.7% | D161A (GAC→GCC) | phnN ← | ribose 1,5‑bisphosphokinase |
| RA | NZ_CP022686 | 3,136,948 | G→T | 8.8% | L158L (CTC→CTA) | phnN ← | ribose 1,5‑bisphosphokinase |
| JC | NZ_CP022686 | 3,196,873 | +GCGTAATCGGTT | 100% | coding (944/1122 nt) | ampC ← | BlaEC family class C beta‑lactamase |
| RA | NZ_CP022686 | 3,265,084 | T→G | 20.4% | N77T (AAC→ACC) | ytfJ ← | YtfJ family protein |
| RA | NZ_CP022686 | 3,297,360 | T→G | 8.4% | L837V (TTA→GTA) | mgtA → | magnesium‑translocating P‑type ATPase |
| RA | NZ_CP022686 | 3,348,342 | A→T | 9.2% | intergenic (‑158/‑42) | CIW80_RS16685 ← / → CIW80_RS26495 | inovirus Gp2 family protein/hypothetical protein |
| RA | NZ_CP022686 | 3,390,616 | C→G | 8.5% | A143P (GCC→CCC) | sgcX ← | M42 family metallopeptidase |
| RA | NZ_CP022686 | 3,424,795 | A→C | 100% | intergenic (‑41/+27) | yjiJ ← / ← yjiK | MFS transporter/YjiK family protein |
| RA | NZ_CP022686 | 3,444,704 | T→G | 12.6% | T530P (ACC→CCC) | btsT ← | pyruvate/proton symporter BtsT |
| RA | NZ_CP022686 | 3,459,370 | C→A | 9.4% | S62Y (TCT→TAT) | bglJ → | DNA‑binding transcriptional activator BglJ |
| RA | NZ_CP022686 | 3,461,200 | C→A | 13.7% | intergenic (‑9/+26) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,215 | A→T | 13.6% | intergenic (‑24/+11) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,218 | G→C | 10.2% | intergenic (‑27/+8) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,229 | T→G | 22.8% | noncoding (84/87 nt) | CIW80_RS17340 ← | tRNA‑Leu |
| RA | NZ_CP022686 | 3,528,197 | A→C | 7.1% | N50T (AAC→ACC) | carB → | carbamoyl‑phosphate synthase large subunit |
| RA | NZ_CP022686 | 3,528,218 | A→C | 9.2% | D57A (GAC→GCC) | carB → | carbamoyl‑phosphate synthase large subunit |
| RA | NZ_CP022686 | 3,570,252 | T→G | 5.9% | L223V (TTG→GTG) | yabI → | DedA family protein |
| RA | NZ_CP022686 | 3,625,683 | T→G | 12.3% | A150A (GCT→GCG) | aceE → | pyruvate dehydrogenase (acetyl‑transferring), homodimeric type |
| RA | NZ_CP022686 | 3,628,523 | T→A | 6.0% | A204A (GCT→GCA) | aceF → | pyruvate dehydrogenase complex dihydrolipoyllysine‑residue acetyltransferase |
| RA | NZ_CP022686 | 3,652,079 | T→G | 8.8% | intergenic (‑88/+24) | panB ← / ← CIW80_RS18255 | 3‑methyl‑2‑oxobutanoate hydroxymethyltransferase/fimbrial‑like adhesin |
| RA | NZ_CP022686 | 3,656,188 | A→G | 100% | S549P (TCC→CCC) | htrE ← | outer membrane usher protein |
| RA | NZ_CP022686 | 3,657,084 | T→G | 6.2% | Y250S (TAC→TCC) | htrE ← | outer membrane usher protein |
| RA | NZ_CP022686 | 3,665,943 | A→C | 11.2% | K474N (AAA→AAC) | hrpB → | ATP‑dependent helicase HrpB |
| RA | NZ_CP022686 | 3,734,380 | T→G | 17.4% | L229R (CTC→CGC) | yafD → | endonuclease/exonuclease/phosphatase family protein |
| RA | NZ_CP022686 | 3,739,795 | T→G | 6.6% | noncoding (70/77 nt) | CIW80_RS18670 → | tRNA‑Asp |
| RA | NZ_CP022686 | 3,770,524 | T→G | 6.4% | intergenic (‑260/+203) | CIW80_RS26265 ← / ← CIW80_RS18890 | ATP‑binding protein/hypothetical protein |
| RA | NZ_CP022686 | 3,792,805 | A→G | 100% | Y421C (TAC→TGC) | fucP → | L‑fucose:H+ symporter permease |
| RA | NZ_CP022686 | 3,797,481 | T→G | 20.5% | L130V (TTA→GTA) | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
| RA | NZ_CP022686 | 3,806,266 | A→C | 10.6% | Y1586S (TAC→TCC) | cdiA → | contact‑dependent inhibition effector tRNA nuclease |
| RA | NZ_CP022686 | 3,852,459 | T→G | 11.9% | N178T (AAC→ACC) | phoE ← | phosphoporin PhoE |
| RA | NZ_CP022686 | 3,868,846 | T→G | 10.7% | T383P (ACG→CCG) | ecpC ← | fimbrial usher EcpC |
| RA | NZ_CP022686 | 3,868,857 | T→G | 8.5% | N379T (AAC→ACC) | ecpC ← | fimbrial usher EcpC |
| RA | NZ_CP022686 | 3,925,279 | T→A | 9.5% | Y153N (TAC→AAC) | prpC → | 2‑methylcitrate synthase |
| RA | NZ_CP022686 | 3,925,289 | A→C | 16.8% | N156T (AAC→ACC) | prpC → | 2‑methylcitrate synthase |
| RA | NZ_CP022686 | 3,928,369 | T→G | 9.2% | W285G (TGG→GGG) | prpE → | propionate‑‑CoA ligase |
| RA | NZ_CP022686 | 3,935,324 | T→G | 10.0% | N705T (AAC→ACC) | lacZ ← | beta‑galactosidase |
| RA | NZ_CP022686 | 3,940,707 | A→C | 8.5% | F314V (TTT→GTT) | frmA ← | S‑(hydroxymethyl)glutathione dehydrogenase |
| RA | NZ_CP022686 | 3,940,724 | A→C | 9.9% | V308G (GTA→GGA) | frmA ← | S‑(hydroxymethyl)glutathione dehydrogenase |
| RA | NZ_CP022686 | 3,949,969 | T→G | 11.1% | D141A (GAC→GCC) | hemB ← | porphobilinogen synthase |
| RA | NZ_CP022686 | 4,004,135 | T→G | 11.4% | R29R (CGT→CGG) | yajQ → | nucleotide binding protein YajQ |
| RA | NZ_CP022686 | 4,014,238 | C→G | 13.8% | intergenic (+84/‑260) | bolA → / → tig | transcriptional regulator BolA/trigger factor |
| RA | NZ_CP022686 | 4,018,222 | C→A | 9.3% | intergenic (+157/‑31) | clpX → / → lon | ATP‑dependent protease ATP‑binding subunit ClpX/endopeptidase La |
| RA | NZ_CP022686 | 4,056,951 | C→A | 15.4% | H134N (CAC→AAC) | adk → | adenylate kinase |
| RA | NZ_CP022686 | 4,056,962 | C→A | 19.8% | F137L (TTC→TTA) | adk → | adenylate kinase |
| RA | NZ_CP022686 | 4,214,457 | G→T | 14.8% | intergenic (‑30/+5) | CIW80_RS21095 ← / ← CIW80_RS21100 | tRNA‑Gln/tRNA‑Gln |
| RA | NZ_CP022686 | 4,234,427 | C→A | 10.1% | intergenic (+127/‑315) | glnS → / → chiP | glutamine‑‑tRNA ligase/chitoporin |
| RA | NZ_CP022686 | 4,368,341 | T→G | 10.6% | D47A (GAC→GCC) | ybiY ← | glycyl‑radical enzyme activating protein |
| RA | NZ_CP022686 | 4,368,380 | T→G | 10.3% | N34T (AAC→ACC) | ybiY ← | glycyl‑radical enzyme activating protein |
| RA | NZ_CP022686 | 4,440,334 | A→T | 17.5% | Q797H (CAA→CAT) | ftsK → | DNA translocase FtsK |
| RA | NZ_CP022686 | 4,445,534 | T→G | 8.6% | intergenic (+40/‑199) | serS → / → dmsA | serine‑‑tRNA ligase/dimethylsulfoxide reductase subunit A |
| RA | NZ_CP022686 | 4,535,349 | A→C | 10.3% | T118T (ACA→ACC) | appA → | bifunctional acid phosphatase/4‑phytase |
| RA | NZ_CP022686 | 4,571,417 | T→G | 8.5% | A66A (GCA→GCC) | pgaC ← | poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine synthase |
| RA | NZ_CP022686 | 4,571,459 | G→T | 11.3% | F52L (TTC→TTA) | pgaC ← | poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine synthase |
| RA | NZ_CP022686 | 4,589,367 | T→G | 7.9% | T247P (ACC→CCC) | CIW80_RS22920 ← | PatB family C‑S lyase |
| RA | NZ_CP022686 | 4,589,371 | C→A | 9.7% | L245L (CTG→CTT) | CIW80_RS22920 ← | PatB family C‑S lyase |
| RA | NZ_CP022686 | 4,605,593 | T→G | 15.2% | Q51P (CAG→CCG) | CIW80_RS23010 ← | hypothetical protein |
| RA | NZ_CP022686 | 4,632,182 | T→G | 10.6% | R276R (CGT→CGG) | mchF → | microcin export transporter peptidase/ATP‑binding subunit MchF |
| RA | NZ_CP022686 | 4,678,041 | A→C | 17.8% | intergenic (+39/‑82) | agn43 → / → CIW80_RS23450 | autotransporter adhesin Ag43/hypothetical protein |
| RA | NZ_CP022686 | 4,678,047 | A→C | 23.6% | intergenic (+45/‑76) | agn43 → / → CIW80_RS23450 | autotransporter adhesin Ag43/hypothetical protein |
| RA | NZ_CP022686 | 4,764,877 | T→G | 10.6% | intergenic (‑57/‑204) | ycfT ← / → lolC | acyltransferase family protein/lipoprotein‑releasing ABC transporter permease subunit LolC |
| RA | NZ_CP022686 | 4,764,904 | G→T | 7.8% | intergenic (‑84/‑177) | ycfT ← / → lolC | acyltransferase family protein/lipoprotein‑releasing ABC transporter permease subunit LolC |
| RA | NZ_CP022686 | 4,764,914 | C→A | 12.7% | intergenic (‑94/‑167) | ycfT ← / → lolC | acyltransferase family protein/lipoprotein‑releasing ABC transporter permease subunit LolC |
| RA | NZ_CP022686 | 4,780,176 | A→C | 18.7% | intergenic (‑75/+95) | phoP ← / ← purB | two‑component system response regulator PhoP/adenylosuccinate lyase |
| RA | NZ_CP022686 | 4,809,441 | T→G | 9.2% | G50G (GGT→GGG) | CIW80_RS24260 → | head‑tail joining protein |
| RA | NZ_CP022686 | 4,870,912 | Δ1 bp | 100% | intergenic (‑108/‑120) | dhaK ← / → dhaR | dihydroxyacetone kinase subunit DhaK/dihydroxyacetone kinase operon transcriptional regulator DhaR |
| RA | NZ_CP022686 | 4,909,248 | A→T | 7.7% | intergenic (‑14/+20) | CIW80_RS24840 ← / ← CIW80_RS24845 | tRNA‑Tyr/tRNA‑Tyr |
| RA | NZ_CP022686 | 4,916,069 | C→A | 6.4% | intergenic (+196/+89) | tdk → / ← CIW80_RS24885 | thymidine kinase/IS4 family transposase |
| RA | NZ_CP022686 | 4,951,998 | T→G | 6.8% | S198A (TCG→GCG) | topA → | type I DNA topoisomerase |
| RA | NZ_CP022686 | 5,043,648 | G→C | 8.2% | V1093V (GTG→GTC) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
| RA | NZ_CP022686 | 5,044,641 | C→T | 5.9% | N1424N (AAC→AAT) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
| RA | pMUT1‑hok‑empty | 1,373 | T→G | 12.8% | intergenic (–/+344) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,376 | Δ1 bp | 100% | intergenic (–/+341) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,392 | T→G | 6.4% | intergenic (–/+325) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,407 | G→T | 11.9% | intergenic (–/+310) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,409 | T→G | 7.5% | intergenic (–/+308) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,413 | T→G | 7.6% | intergenic (–/+304) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,423 | G→T | 7.3% | intergenic (–/+294) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,430 | G→T | 15.2% | intergenic (–/+287) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,441 | G→T | 9.4% | intergenic (–/+276) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 1,449 | C→A | 9.4% | intergenic (–/+268) | – / ← putative HTH domain protein | –/– |
| RA | pMUT1‑hok‑empty | 2,078:1 | +A | 38.9% | intergenic (‑44/‑113) | putative HTH domain protein ← / → uncharacterized protein | –/– |
| RA | pMUT1‑hok‑empty | 4,123:1 | +T | 94.6% | intergenic (‑341/–) | putative rom (RNA I inhibition modulator protein) ← / – | –/– |
| RA | pMUT1‑hok‑empty | 4,127 | C→A | 100% | intergenic (‑345/–) | putative rom (RNA I inhibition modulator protein) ← / – | –/– |
| RA | pMUT1‑hok‑empty | 4,132 | 4 bp→TA | 100% | intergenic (‑350/–) | putative rom (RNA I inhibition modulator protein) ← / – | –/– |
| Unassigned missing coverage evidence | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| seq id | start | end | size | ←reads | reads→ | gene | description | |||
| * | * | ÷ | NZ_MW240712 | 682–2618 | 3043–2957 | 340–2362 | 6726 [6681] | [6647] 7008 | JNG15_RS00010–mobA | JNG15_RS00010,JNG15_RS00015,mobA |
| Unassigned new junction evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NZ_CP022686 | 3899666 = | 271 (1.260) | 17 (0.090) | 12/218 | NT | 7.1% | intergenic (‑40/+290) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA |
| ? | NZ_CP022686 | 3899944 = | 208 (1.110) | intergenic (‑318/+12) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA | |||||
| * | ? | NZ_CP022686 | = 3899681 | 260 (1.210) | 28 (0.150) | 18/218 | NT | 11.4% | intergenic (‑55/+275) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA |
| ? | NZ_CP022686 | = 3899927 | 208 (1.110) | intergenic (‑301/+29) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA | |||||
| * | ? | pMUT1‑hok‑empty | 456 = | 4262 (0.420) | 6350 (0.630) | 199/250 | NT | 67.6% | intergenic (–/+1261) | –/putative HTH domain protein | –/– |
| ? | pMUT1‑hok‑empty | 4136 = | 1822 (0.180) | intergenic (‑354/–) | putative rom (RNA I inhibition modulator protein)/– | –/– | |||||
| * | ? | pMUT1‑hok‑empty | = 491 | 6396 (0.640) | 5028 (0.620) | 162/200 | NT | 59.2% | intergenic (–/+1226) | –/putative HTH domain protein | –/– |
| ? | pMUT1‑hok‑empty | = 4098 | 1821 (0.230) | intergenic (‑316/–) | putative rom (RNA I inhibition modulator protein)/– | –/– | |||||